Abaloparatide Subcutaneous and Emtricitabine, rilpivirine, and tenofovir
Determining the interaction of Abaloparatide Subcutaneous and Emtricitabine, rilpivirine, and tenofovir and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: abaloparatide
Brand name: Tymlos
Synonyms: Abaloparatide
Generic Name: emtricitabine / rilpivirine / tenofovir
Brand name: Complera, Odefsey
Synonyms: Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Fumarate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abaloparatide Subcutaneous-Emtricitabine, Rilpivirine, and Tenofovir Alafenamide
- Abaloparatide Subcutaneous-Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Fumarate
- Abaloparatide Subcutaneous-Emtriva
- Abaloparatide Subcutaneous-Emtriva (Emtricitabine Capsules)
- Abaloparatide Subcutaneous-Emtriva (Emtricitabine Solution)
- Abaloparatide Subcutaneous-Emverm
- Emtricitabine, rilpivirine, and tenofovir-Abatacept
- Emtricitabine, rilpivirine, and tenofovir-Abatacept Auto-Injectors
- Emtricitabine, rilpivirine, and tenofovir-Abatacept Infusion
- Emtricitabine, rilpivirine, and tenofovir-Abatacept Intravenous
- Emtricitabine, rilpivirine, and tenofovir-Abatacept Prefilled Syringes
- Emtricitabine, rilpivirine, and tenofovir-Abatron